Document is current

Article History

Received: 23 August 2021

Accepted: 3 November 2021

First Online: 27 November 2021

Declarations

:

: The clinical study was approved by the ethic committee in Rush University Medical Center (Approval No. 18102503-IRB01)<b>.</b> Written consent was waived by the ethic committee in Rush University Medical Center.

: Not applicable.

: Dr. Li declares to receive research funding from Fisher & Paykel Healthcare Ltd, Aerogen Ltd, and Rice Foundation and lecture honorarium from American Association for Respiratory Care, Aerogen Ltd, Heyer Ltd, and Fisher & Paykel Healthcare Ltd outside the submitted work. Dr. Li is the section editor for respiratory care journal. Dr. Scott declares to receive research funding from Teleflex. Dr. Fink is Chief Science Officer for Aerogen Pharma Corp. Dr. Dhand reports remuneration from GSK Pharmaceuticals, Boehringer-Ingelheim, Bayer, Mylan, Teva, and Astra-Zeneca Pharmaceuticals outside the submitted work. Dr. Roca discloses a research grant from Hamilton Medical and speaker fees from Hamilton Medical, Ambu, Aerogen Ltd, and Fisher & Paykel, and non-financial research support from Timpel and Masimo Corporation. None of the companies/institutions had a role in the study design, data collection, analysis, preparation of the manuscript, or the decision to publish the findings. Ms. Reed has no conflicts to disclose.